Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation

Alemtuzumab is a humanized monoclonal antibody against CD52 and causes depletion of T and B lymphocytes, monocytes, and NK cells. Alemtuzumab is registered for the treatment of multiple sclerosis (MS) and is also used in chronic lymphocytic leukemia (CLL). Alemtuzumab is used off-label in kidney tra...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Zwan, Marieke, Baan, Carla C., van Gelder, Teun, Hesselink, Dennis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784003/
https://www.ncbi.nlm.nih.gov/pubmed/28669130
http://dx.doi.org/10.1007/s40262-017-0573-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784003/
https://www.ncbi.nlm.nih.gov/pubmed/28669130
http://dx.doi.org/10.1007/s40262-017-0573-x

Ejemplares similares